Q1 Results: Smallcap drugmaker shares surge 9% after earnings report

Lincoln Pharma is targeting revenue of ₹1,000 crore within the next three years, driven by business expansion into high-value product lines and entry into new markets.

Leave a Reply

Your email address will not be published. Required fields are marked *